At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 24 enrolled
Drug / intervention
Daivobet® ointment +5 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Plaque Test Comparing 4 Steroids With Daivobet® Ointment and a Vehicle Control for the Treatment of Psoriasis Vulgaris
In Brief
A Phase 2 clinical trial evaluating Daivobet® ointment, Betnovat® ointment, and 4 other interventions for Psoriasis Vulgaris. Completed, enrolled 24 participants across 1 site.
Detailed Summary
The purpose of the study is to compare the anti-psoriatic effect of marketed products with Daivobet® ointment in a plaque test
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPsoriasis Vulgaris
CountriesFrance
Collaborators--
Timeline
Phase 2CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2009
First PostedFeb 2009
Primary CompletionMar 2009
Study CompletionMay 2009
TodayJul 2026
First PostedFeb 18, 2009
Enrollment StartJan 1, 2009
Primary CompletionMar 1, 2009
Study CompletionMay 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 17.4 years ago
Interventions
Daivobet® ointmentdrug
Once daily application 6 days a week for 3 weeks
Betnovat® ointmentdrug
Once daily application 6 days a week for 3 weeks
Diprosalic ointmentdrug
Once daily application 6 days a week for 3 weeks
Dermovat ointmentdrug
Once daily application 6 days a week for 3 weeks
Elocon ointmentdrug
Once daily application 6 days a week for 3 weeks
Daivobet® ointment vehicledrug
Once daily application 6 days a week for 3 weeks